Free water imaging of the cholinergic forebrain in body vs. brain-first Parkinson’s disease subtypes
Objective: To investigate the relationship between basal forebrain (BF) neurodegeneration and cholinergic system in body vs brain-first Parkinson’s disease (PD) subtypes. Background: Free water imaging…Clinical features and phenoconversion risk in women with isolated REM sleep behavior disorder
Objective: To determine features predictive of differential phenoconversion rates in isolated REM sleep Behavior Disorder (iRBD) to a defined neurodegenerative disease (NDD). Background: iRBD is…Analysis of a wearable sensor, STAT-on®, to detect motor complications in patients with Parkinson´s disease (PDp)
Objective: Analysis of the use of a personalized monitoring device, STAT-on®, to detect motor complications in PDp and its impact on the therapeutic approach. Background:…Correlates of gait impairment in parkinson’s disease
Objective: Assess gait dysfunction in patients with PD and its correlation with clinical (motor and non-motor symptoms) and radiological findings. Background: Gait impairment is one…Supra-ON state freezing of gait: The unpredictable response to levodopa in Parkinson´s Disease
Objective: To discuss the therapeutic dilemma of freezing in supra ON Background: Freezing of gait (FOG) is a common manifestation of Parkinson's disease (PD), occurring…Palliative Care in Parkinson: a family caregiver’s view. A PD-PAL Consortium initiative.
Objective: We aim to identify clinical indicators and markers for timely referral, access, and need of PC in our PwP community, from the viewpoint of…The study of genetic factors in levodopa-induced motor complications development in Russian patients with Parkinson’s disease
Objective: This study is aimed to explore the relationship between the single nucleotide polymorphisms (SNPs) in dopamine and serotonin metabolism genes, other neurotransmitter systems genes…Correlation between dose of dopamine replacement therapy and King’s Parkinson’s Disease Pain Scale in Mexican Patients with Parkinson’s Disease
Objective: Investigate the relationship between the dose of dopamine replacement therapy (DRT) and pain severity as measured by the King's Parkinson's Disease Pain Scale (KPPS)…Amantadine Delayed Release/Extended Release Capsules Reduce the Proportion of the Day Spent in “BAD” Time (ON with Troublesome Dyskinesia or OFF): Analysis of Phase 3 Trial Data
Objective: To evaluate the effect of treatment with amantadine delayed release/extended release (AMT DR/ER) vs. placebo on the proportion of the waking day spent in…Sex Differences for Tau Association with Cognition in Early Parkinson’s Disease
Objective: To assess sex differences for cerebrospinal fluid (CSF) phosphorylated tau (p-tau) association with cognition in Parkinson’s disease (PD) Background: Tau biomarkers can predict cognitive…
- « Previous Page
- 1
- …
- 288
- 289
- 290
- 291
- 292
- …
- 436
- Next Page »